Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Julie M. Zito |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus / Mehmet Burcu en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2017 - Vol.56 - No.8 ([25/09/2017])
[artículo]
Título : Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus Tipo de documento: texto impreso Autores: Mehmet Burcu, Autor ; Julie M. Zito, Autor Fecha de publicación: 2017 Artículo en la página: pp. 642-651 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Diabetes Mellitus Tipo 2, Antipsicóticos Atípicos, Antidepresivos, Estimulantes, Medicaid. Resumen: More than half of youth treated with atypical antipsychotic (AAP) medications are also treated with concomitant antidepressants or stimulants. This study assessed the association between antidepressant or stimulant use concomitant with AAPs and the risk of incident type 2 diabetes mellitus (T2DM). Link: ./index.php?lvl=notice_display&id=9590
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol.56 - No.8 [25/09/2017] . - pp. 642-651[artículo] Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus [texto impreso] / Mehmet Burcu, Autor ; Julie M. Zito, Autor . - 2017 . - pp. 642-651.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol.56 - No.8 [25/09/2017] . - pp. 642-651
Palabras clave: Diabetes Mellitus Tipo 2, Antipsicóticos Atípicos, Antidepresivos, Estimulantes, Medicaid. Resumen: More than half of youth treated with atypical antipsychotic (AAP) medications are also treated with concomitant antidepressants or stimulants. This study assessed the association between antidepressant or stimulant use concomitant with AAPs and the risk of incident type 2 diabetes mellitus (T2DM). Link: ./index.php?lvl=notice_display&id=9590